Lessons from the withdrawal of rofecoxib: Observational studies should not be forgotten.
Oakley
Godfrey
G
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D002318:Cardiovascular Diseases / Q000139:chemically induced; D017277:Drug Approval; D006801:Humans; D007783:Lactones / Q000009:adverse effects*; D016032:Randomized Controlled Trials as Topic; D013450:Sulfones
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib